Search

Search Constraints

You searched for: Author/Creator Partridge, A.

Search Results

2. Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials. (August 2019)